Drug intelligence / Profile preview

Diazepam and pethidine combination

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous, Intramuscular, Oral
01

Overview

The combination of diazepam and pethidine is used primarily for pain management and sedation, particularly during medical procedures. This combination leverages the anxiolytic and muscle relaxant properties of diazepam with the analgesic effects of pethidine. ## Pharmacology and Mechanism of Action Diazepam is a benzodiazepine that works by enhancing the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits brain activity. It produces a calming effect on the brain and nerves, which helps prevent seizures, reduce anxiety symptoms, and relax muscles. Pethidine (meperidine) is an opioid analgesic that binds to opioid receptors in the brain and spinal cord, reducing the perception of pain and producing sedation. When combined, these medications provide both pain relief and sedation, making them useful for procedures that may cause discomfort or anxiety. ## Clinical Applications The combination of diazepam and pethidine has been shown to be effective for: - Pain control during medical procedures, particularly extracorporeal shock wave lithotripsy (ESWL) - Sedation for invasive procedures - Management of acute pain with associated anxiety A study comparing this combination to diclofenac sodium plus hyoscine-N-butyl bromide found that pethidine with diazepam provided superior pain control during ESWL procedures. ## Safety Concerns The FDA has issued strong warnings about combining opioids (such as pethidine) with benzodiazepines (such as diazepam) due to serious risks including: - Slowed or difficult breathing - Sedation - Potential for coma - Increased risk of death Due to these concerns, the FDA has added Boxed Warnings (their strongest warning) to the labeling of prescription opioid pain medicines and benzodiazepines. ## Dosing Considerations Dosing must be carefully determined on an individual basis, considering: - The condition being treated - Severity of symptoms - Patient body weight - Other conditions the person may have The combination should be used under close medical supervision due to the potential for respiratory depression and other serious side effects.

Other names
Pethidine and diazepam combinationMeperidine and diazepam combination
02

Targets

MOR (Mu opioid receptor)GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on Diazepam and pethidine combination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diazepam and pethidine combination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call